Administration of 5-HT.sub.3 receptor antagonists to treat premature ejaculation
US6037360A · kind A · utility
5Cited by
23References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1997 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | Oct 28, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for delaying the onset of ejaculation in an individual. The method involves administration of a 5-HT.sub.3 receptor antagonist within the context of an effective dosing regimen. The preferred mode of administration is transurethral; however, the selected inhibitor may also be delivered via intracavernosal injection or using alternative routes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.